Predictors for the development of microalbuminuria and interaction with renal function

Area of Science:

• Nephrology
• Endocrinology
• Cardiology

Background:

• Microalbuminuria is a key indicator of diabetic kidney disease.
• Identifying predictors of microalbuminuria is crucial for early intervention in type 2 diabetes mellitus.
• Understanding the role of baseline albuminuria and estimated glomerular filtration rate (eGFR) is important for managing diabetic nephropathy.

Purpose of the Study:

• To identify predictors of new-onset microalbuminuria in patients with type 2 diabetes.
• To investigate the interaction between baseline albuminuria and eGFR.
• To evaluate the effects of olmesartan on microalbuminuria development and renal function.

Main Methods:

• Analysis of data from the Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study.
• Randomization of 4447 patients to receive olmesartan or placebo for a median of 3.2 years.
• Assessment of baseline urinary albumin-creatinine ratio (UACR), eGFR, and other cardiovascular risk factors.

Main Results:

• Baseline UACR was the strongest predictor of microalbuminuria, followed by age, weight, HbA1C, glucose, cholesterol, SBP, antihypertensive drug count, and heart rate.
• Microalbuminuria incidence increased with higher baseline UACR tertiles across all eGFR tertiles.
• Olmesartan showed greater efficacy in preventing microalbuminuria in patients with higher baseline UACR, but led to a more significant eGFR decline, particularly in those with high baseline eGFR.

Conclusions:

• Classical cardiovascular risk factors, particularly baseline UACR, predict microalbuminuria development in type 2 diabetes.
• Olmesartan's effect on microalbuminuria prevention and eGFR decline may involve different mechanisms, as eGFR decrease was dependent on baseline eGFR, not UACR.
• The transition to microalbuminuria under olmesartan treatment was not associated with renal function preservation.